Emulsion formulations of testosterone for nasal administration
Abstract The nasal route has received a great deal of attention due to the many advantages of nasal delivery over parenteral administration. The male sex hormone testosterone is ineffective when administered orally due to its gut wall and first-pass metabolism. Therefore, an alternative method for d...
Gespeichert in:
Veröffentlicht in: | Journal of microencapsulation 1998, Vol.15 (2), p.197-205 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 205 |
---|---|
container_issue | 2 |
container_start_page | 197 |
container_title | Journal of microencapsulation |
container_volume | 15 |
creator | Ko, Kuang-Ta Needham, T. E. Zia, H. |
description | Abstract
The nasal route has received a great deal of attention due to the many advantages of nasal delivery over parenteral administration. The male sex hormone testosterone is ineffective when administered orally due to its gut wall and first-pass metabolism. Therefore, an alternative method for delivery would he the intranasal route, if the lack of aqueous solubility can be overcome. In this study a new approach to emulsion formulations of the drug has been proposed based on the hypothesis that increased absorption is possible upon solubilization of the drug and/or prolongation of the formulation residence time in the nose. Three differently charged testosterone submicron size emulsion formulations with various zeta potentials (+24.8,-23.0 and 0.06mV) were prepared as nasal spray formulations. A dose of approximately 3.8 mg testosterone per rabbit was administered to four rabbits and the bioavailability of the emulsion formulations was assessed and compared with an i.v. formulation via solid-phase extraction, followed by an HPLC analysis method. Statistical analysis of the normalized data indicated a bioavailability of 55, 51 and 37% for positively, negatively and neutrally charged emulsions respectively. The results of this study strongly suggest that emulsion formulations have some potential to be considered for nasal delivery. Further, both the positively and negatively charged emulsion formulations provided a better bioavailability than the neutral charged emulsion, probably indicating that the charged particle interactions between emulsion globules and the mucus layer prolong the contact of drug with nasal membrane thus enhancing drug absorption. |
doi_str_mv | 10.3109/02652049809006849 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_2178085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79766660</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-4842dcefbaf34a313b7141fee38b8f753ce453fb20de460fee9f99bc60f745a33</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMoOj5-gAuhC3FXzbNNUAQRXyC40XW5TROmQ9qMSYv4702dcUAEs8mB853LvQehY4LPGcHqAtNCUMyVxArjQnK1hWaEFzwXlBfbaDb5eQLkHtqPcYExFkrSXbSrBKOCihm6vutGF1vfZ9aHJGFIOmbeZoOJg4-DCb43k5n1EMFl0HRt38YhfJOHaMeCi-Zo_R-gt_u719vH_Pnl4en25jnXnOEh55LTRhtbg2UcGGF1STixxjBZS1sKpg0XzNYUN4YXOBnKKlXrJEsugLEDdLaauwz-fUybVV0btXEOeuPHWJWqLNLDCSQrUAcfYzC2Woa2g_BZEVxNnVV_OkuZk_Xwse5Ms0msS0r-6dqHqMHZAL1u4wajpJRYTtjVCmv7qUv48ME11QCfzoefDPtvi8tf8bkBN8w1BFMt_Bj6VO8_N3wBYXWZ5w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79766660</pqid></control><display><type>article</type><title>Emulsion formulations of testosterone for nasal administration</title><source>MEDLINE</source><source>Taylor & Francis</source><source>Taylor & Francis Medical Library - CRKN</source><creator>Ko, Kuang-Ta ; Needham, T. E. ; Zia, H.</creator><creatorcontrib>Ko, Kuang-Ta ; Needham, T. E. ; Zia, H.</creatorcontrib><description>Abstract
The nasal route has received a great deal of attention due to the many advantages of nasal delivery over parenteral administration. The male sex hormone testosterone is ineffective when administered orally due to its gut wall and first-pass metabolism. Therefore, an alternative method for delivery would he the intranasal route, if the lack of aqueous solubility can be overcome. In this study a new approach to emulsion formulations of the drug has been proposed based on the hypothesis that increased absorption is possible upon solubilization of the drug and/or prolongation of the formulation residence time in the nose. Three differently charged testosterone submicron size emulsion formulations with various zeta potentials (+24.8,-23.0 and 0.06mV) were prepared as nasal spray formulations. A dose of approximately 3.8 mg testosterone per rabbit was administered to four rabbits and the bioavailability of the emulsion formulations was assessed and compared with an i.v. formulation via solid-phase extraction, followed by an HPLC analysis method. Statistical analysis of the normalized data indicated a bioavailability of 55, 51 and 37% for positively, negatively and neutrally charged emulsions respectively. The results of this study strongly suggest that emulsion formulations have some potential to be considered for nasal delivery. Further, both the positively and negatively charged emulsion formulations provided a better bioavailability than the neutral charged emulsion, probably indicating that the charged particle interactions between emulsion globules and the mucus layer prolong the contact of drug with nasal membrane thus enhancing drug absorption.</description><identifier>ISSN: 0265-2048</identifier><identifier>EISSN: 1464-5246</identifier><identifier>DOI: 10.3109/02652049809006849</identifier><identifier>PMID: 9532525</identifier><identifier>CODEN: JOMIEF</identifier><language>eng</language><publisher>Colchester: Informa UK Ltd</publisher><subject>Absorption - physiology ; Administration, Intranasal ; Animals ; bioavailability ; Biological and medical sciences ; Biological Availability ; Chemistry, Pharmaceutical ; Drug Compounding - methods ; Drug Delivery Systems - methods ; emulsions ; Emulsions - chemistry ; General pharmacology ; Hormones. Endocrine system ; Injections, Intravenous ; Medical sciences ; Nasal delivery ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Rabbits ; Solubility ; Static Electricity ; testosterone ; Testosterone - chemistry ; Testosterone - pharmacokinetics ; zeta potential nasal formulations</subject><ispartof>Journal of microencapsulation, 1998, Vol.15 (2), p.197-205</ispartof><rights>1998 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1998</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-4842dcefbaf34a313b7141fee38b8f753ce453fb20de460fee9f99bc60f745a33</citedby><cites>FETCH-LOGICAL-c430t-4842dcefbaf34a313b7141fee38b8f753ce453fb20de460fee9f99bc60f745a33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/02652049809006849$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/02652049809006849$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,777,781,4010,27904,27905,27906,59626,59732,60415,60521,61200,61235,61381,61416</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2178085$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9532525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ko, Kuang-Ta</creatorcontrib><creatorcontrib>Needham, T. E.</creatorcontrib><creatorcontrib>Zia, H.</creatorcontrib><title>Emulsion formulations of testosterone for nasal administration</title><title>Journal of microencapsulation</title><addtitle>J Microencapsul</addtitle><description>Abstract
The nasal route has received a great deal of attention due to the many advantages of nasal delivery over parenteral administration. The male sex hormone testosterone is ineffective when administered orally due to its gut wall and first-pass metabolism. Therefore, an alternative method for delivery would he the intranasal route, if the lack of aqueous solubility can be overcome. In this study a new approach to emulsion formulations of the drug has been proposed based on the hypothesis that increased absorption is possible upon solubilization of the drug and/or prolongation of the formulation residence time in the nose. Three differently charged testosterone submicron size emulsion formulations with various zeta potentials (+24.8,-23.0 and 0.06mV) were prepared as nasal spray formulations. A dose of approximately 3.8 mg testosterone per rabbit was administered to four rabbits and the bioavailability of the emulsion formulations was assessed and compared with an i.v. formulation via solid-phase extraction, followed by an HPLC analysis method. Statistical analysis of the normalized data indicated a bioavailability of 55, 51 and 37% for positively, negatively and neutrally charged emulsions respectively. The results of this study strongly suggest that emulsion formulations have some potential to be considered for nasal delivery. Further, both the positively and negatively charged emulsion formulations provided a better bioavailability than the neutral charged emulsion, probably indicating that the charged particle interactions between emulsion globules and the mucus layer prolong the contact of drug with nasal membrane thus enhancing drug absorption.</description><subject>Absorption - physiology</subject><subject>Administration, Intranasal</subject><subject>Animals</subject><subject>bioavailability</subject><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>Chemistry, Pharmaceutical</subject><subject>Drug Compounding - methods</subject><subject>Drug Delivery Systems - methods</subject><subject>emulsions</subject><subject>Emulsions - chemistry</subject><subject>General pharmacology</subject><subject>Hormones. Endocrine system</subject><subject>Injections, Intravenous</subject><subject>Medical sciences</subject><subject>Nasal delivery</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Rabbits</subject><subject>Solubility</subject><subject>Static Electricity</subject><subject>testosterone</subject><subject>Testosterone - chemistry</subject><subject>Testosterone - pharmacokinetics</subject><subject>zeta potential nasal formulations</subject><issn>0265-2048</issn><issn>1464-5246</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLxDAUhYMoOj5-gAuhC3FXzbNNUAQRXyC40XW5TROmQ9qMSYv4702dcUAEs8mB853LvQehY4LPGcHqAtNCUMyVxArjQnK1hWaEFzwXlBfbaDb5eQLkHtqPcYExFkrSXbSrBKOCihm6vutGF1vfZ9aHJGFIOmbeZoOJg4-DCb43k5n1EMFl0HRt38YhfJOHaMeCi-Zo_R-gt_u719vH_Pnl4en25jnXnOEh55LTRhtbg2UcGGF1STixxjBZS1sKpg0XzNYUN4YXOBnKKlXrJEsugLEDdLaauwz-fUybVV0btXEOeuPHWJWqLNLDCSQrUAcfYzC2Woa2g_BZEVxNnVV_OkuZk_Xwse5Ms0msS0r-6dqHqMHZAL1u4wajpJRYTtjVCmv7qUv48ME11QCfzoefDPtvi8tf8bkBN8w1BFMt_Bj6VO8_N3wBYXWZ5w</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>Ko, Kuang-Ta</creator><creator>Needham, T. E.</creator><creator>Zia, H.</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><general>Informa</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Emulsion formulations of testosterone for nasal administration</title><author>Ko, Kuang-Ta ; Needham, T. E. ; Zia, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-4842dcefbaf34a313b7141fee38b8f753ce453fb20de460fee9f99bc60f745a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Absorption - physiology</topic><topic>Administration, Intranasal</topic><topic>Animals</topic><topic>bioavailability</topic><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>Chemistry, Pharmaceutical</topic><topic>Drug Compounding - methods</topic><topic>Drug Delivery Systems - methods</topic><topic>emulsions</topic><topic>Emulsions - chemistry</topic><topic>General pharmacology</topic><topic>Hormones. Endocrine system</topic><topic>Injections, Intravenous</topic><topic>Medical sciences</topic><topic>Nasal delivery</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Rabbits</topic><topic>Solubility</topic><topic>Static Electricity</topic><topic>testosterone</topic><topic>Testosterone - chemistry</topic><topic>Testosterone - pharmacokinetics</topic><topic>zeta potential nasal formulations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ko, Kuang-Ta</creatorcontrib><creatorcontrib>Needham, T. E.</creatorcontrib><creatorcontrib>Zia, H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of microencapsulation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ko, Kuang-Ta</au><au>Needham, T. E.</au><au>Zia, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emulsion formulations of testosterone for nasal administration</atitle><jtitle>Journal of microencapsulation</jtitle><addtitle>J Microencapsul</addtitle><date>1998</date><risdate>1998</risdate><volume>15</volume><issue>2</issue><spage>197</spage><epage>205</epage><pages>197-205</pages><issn>0265-2048</issn><eissn>1464-5246</eissn><coden>JOMIEF</coden><abstract>Abstract
The nasal route has received a great deal of attention due to the many advantages of nasal delivery over parenteral administration. The male sex hormone testosterone is ineffective when administered orally due to its gut wall and first-pass metabolism. Therefore, an alternative method for delivery would he the intranasal route, if the lack of aqueous solubility can be overcome. In this study a new approach to emulsion formulations of the drug has been proposed based on the hypothesis that increased absorption is possible upon solubilization of the drug and/or prolongation of the formulation residence time in the nose. Three differently charged testosterone submicron size emulsion formulations with various zeta potentials (+24.8,-23.0 and 0.06mV) were prepared as nasal spray formulations. A dose of approximately 3.8 mg testosterone per rabbit was administered to four rabbits and the bioavailability of the emulsion formulations was assessed and compared with an i.v. formulation via solid-phase extraction, followed by an HPLC analysis method. Statistical analysis of the normalized data indicated a bioavailability of 55, 51 and 37% for positively, negatively and neutrally charged emulsions respectively. The results of this study strongly suggest that emulsion formulations have some potential to be considered for nasal delivery. Further, both the positively and negatively charged emulsion formulations provided a better bioavailability than the neutral charged emulsion, probably indicating that the charged particle interactions between emulsion globules and the mucus layer prolong the contact of drug with nasal membrane thus enhancing drug absorption.</abstract><cop>Colchester</cop><pub>Informa UK Ltd</pub><pmid>9532525</pmid><doi>10.3109/02652049809006849</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0265-2048 |
ispartof | Journal of microencapsulation, 1998, Vol.15 (2), p.197-205 |
issn | 0265-2048 1464-5246 |
language | eng |
recordid | cdi_pascalfrancis_primary_2178085 |
source | MEDLINE; Taylor & Francis; Taylor & Francis Medical Library - CRKN |
subjects | Absorption - physiology Administration, Intranasal Animals bioavailability Biological and medical sciences Biological Availability Chemistry, Pharmaceutical Drug Compounding - methods Drug Delivery Systems - methods emulsions Emulsions - chemistry General pharmacology Hormones. Endocrine system Injections, Intravenous Medical sciences Nasal delivery Particle Size Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Rabbits Solubility Static Electricity testosterone Testosterone - chemistry Testosterone - pharmacokinetics zeta potential nasal formulations |
title | Emulsion formulations of testosterone for nasal administration |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A13%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emulsion%20formulations%20of%20testosterone%20for%20nasal%20administration&rft.jtitle=Journal%20of%20microencapsulation&rft.au=Ko,%20Kuang-Ta&rft.date=1998&rft.volume=15&rft.issue=2&rft.spage=197&rft.epage=205&rft.pages=197-205&rft.issn=0265-2048&rft.eissn=1464-5246&rft.coden=JOMIEF&rft_id=info:doi/10.3109/02652049809006849&rft_dat=%3Cproquest_pasca%3E79766660%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79766660&rft_id=info:pmid/9532525&rfr_iscdi=true |